2,2',2''-trichlorotriethylamine has been researched along with Local Neoplasm Recurrence in 1 studies
2,2',2''-trichlorotriethylamine: RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)." | 1.28 | Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koza, I | 1 |
| Bohunický, L | 1 |
| Svancárová, L | 1 |
| Mardiak, J | 1 |
| Gyárfás, J | 1 |
| Cerný, V | 1 |
1 other study available for 2,2',2''-trichlorotriethylamine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1989 |